Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Sex differences in fuel use and metabolism during development in fasting juvenile northern elephant seals.

Kelso EJ, Champagne CD, Tift MS, Houser DS, Crocker DE.

J Exp Biol. 2012 Aug 1;215(Pt 15):2637-45. doi: 10.1242/jeb.068833.

2.

Effects of an endothelin receptor antagonist on a model of hypertensive retinopathy.

McDonald L, Lee GR, Degooyer TE, McDonald D, Canning P, Kelso EJ, McDermott BJ, Stitt AW.

Ophthalmic Res. 2010;43(2):99-107. doi: 10.1159/000247594. Epub 2009 Oct 15.

3.

SRIF receptor subtype expression and involvement in positive and negative contractile effects of somatostatin-14 (SRIF-14) in ventricular cardiomyocytes.

Bell D, Zhao Y, McMaster B, McHenry EM, Wang X, Kelso EJ, McDermott BJ.

Cell Physiol Biochem. 2008;22(5-6):653-64. doi: 10.1159/000185549. Epub 2008 Dec 9.

4.

Activation of immune and inflammatory systems in chronic heart failure: novel therapeutic approaches.

Gong KZ, Song G, Spiers JP, Kelso EJ, Zhang ZG.

Int J Clin Pract. 2007 Apr;61(4):611-21. Review.

PMID:
17394435
5.

Protection of cardiomyocyte function by propofol during simulated ischemia is associated with a direct action to reduce pro-oxidant activity.

McDermott BJ, McWilliams S, Smyth K, Kelso EJ, Spiers JP, Zhao Y, Bell D, Mirakhur RK.

J Mol Cell Cardiol. 2007 Mar;42(3):600-8. Epub 2007 Feb 27.

PMID:
17328910
6.

Modulation of contractile function through neuropeptide Y receptors during development of cardiomyocyte hypertrophy.

Allen AR, Kelso EJ, Bell D, Zhao Y, Dickson P, McDermott BJ.

J Pharmacol Exp Ther. 2006 Dec;319(3):1286-96. Epub 2006 Sep 14.

PMID:
16973886
7.

Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade.

Spiers JP, Kelso EJ, Siah WF, Edge G, Song G, McDermott BJ, Hennessy M.

J Hypertens. 2005 Sep;23(9):1717-24.

PMID:
16093917
8.

Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats.

Bell D, Zhao YY, Kelso EJ, McHenry EM, Rush LM, Lamont VM, Nicholls DP, McDermott BJ.

Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H904-14. Epub 2005 Jul 22.

9.

Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat.

Bell D, Kelso EJ, Argent CC, Lee GR, Allen AR, McDermott BJ.

Cardiovasc Pathol. 2004 Mar-Apr;13(2):71-8.

PMID:
15033155
10.

Evidence for altered ETB receptor characteristics during development and progression of ventricular cardiomyocyte hypertrophy.

Lee GR, Bell D, Kelso EJ, Argent CC, McDermott BJ.

Am J Physiol Heart Circ Physiol. 2004 Jul;287(1):H425-32. Epub 2004 Feb 26.

11.

Induction of hypertrophic responsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload.

Bell D, Allen AR, Kelso EJ, Balasubramaniam A, McDermott BJ.

J Pharmacol Exp Ther. 2002 Nov;303(2):581-91.

PMID:
12388639
12.

Myocardial expression of the endothelin system in endotoxin-treated rats.

Spiers JP, Dorman A, Allen JD, Kelso EJ, Silke B, McDermott BJ.

J Cardiovasc Pharmacol. 2001 Aug;38(2):259-67.

PMID:
11483876
13.

Use of A-192621 to provide evidence for involvement of endothelin ET(B)-receptors in endothelin-1-mediated cardiomyocyte hypertrophy.

Cullen JP, Bell D, Kelso EJ, McDermott BJ.

Eur J Pharmacol. 2001 Apr 13;417(3):157-68.

PMID:
11334846
14.

Positive and negative contractile effects of somatostatin-14 on rat ventricular cardiomyocytes.

Murray F, Bell D, Kelso EJ, Millar BC, McDermott BJ.

J Cardiovasc Pharmacol. 2001 Mar;37(3):324-32.

PMID:
11243423
15.

Endothelin(A) receptor subtype mediates endothelin-induced contractility in left ventricular cardiomyocytes isolated from rabbit myocardium.

Kelso EJ, McDermott BJ, Silke B, Spiers JP.

J Pharmacol Exp Ther. 2000 Sep;294(3):1047-52.

PMID:
10945858
16.
17.

Receptor-mediated effects of endothelin on the L-type Ca++ current in ventricular cardiomyocytes.

Kelso EJ, Spiers JP, McDermott BJ, Scholfield CN, Silke B.

J Pharmacol Exp Ther. 1998 Aug;286(2):662-9.

PMID:
9694918
18.

Stimulation of L-type Ca2+ current by the endothelin receptor A-selective antagonist, BQ-123 in ventricular cardiomyocytes isolated from the rabbit myocardium.

Kelso EJ, Spiers JP, McDermott BJ, Scholfield CN, Silke B.

Biochem Pharmacol. 1998 Mar 15;55(6):897-902.

PMID:
9586963
19.

Characterisation of a cellular model of cardiomyopathy, in the rabbit, produced by chronic administration of the anthracycline, epirubicin.

Kelso EJ, Geraghty RF, McDermott BJ, Cameron CH, Nicholls DP, Silke B.

J Mol Cell Cardiol. 1997 Dec;29(12):3385-97.

PMID:
9441844
20.

Economic evaluation of the use of nadroparin calcium in the prophylaxis of deep vein thrombosis and pulmonary embolism in surgical patients in Italy.

Lloyd A, Aitken JA, Hoffmeyer UK, Kelso EJ, Wakerly EC, Barber ND.

Pharmacoeconomics. 1997 Oct;12(4):475-85.

PMID:
10174313
21.

Economic evaluation of the use of nadroparin in the treatment of deep-vein thrombosis in Switzerland.

Lloyd AC, Aitken JA, Hoffmeyer UK, Kelso EJ, Wakerly EC, Barber ND.

Ann Pharmacother. 1997 Jul-Aug;31(7-8):842-6.

PMID:
9220041
22.

Involvement of endothelin (ET)A and ETB receptors in the hypertrophic effects of ET-1 in rabbit ventricular cardiomyocytes.

Mullan DM, Bell D, Kelso EJ, McDermott BJ.

J Cardiovasc Pharmacol. 1997 Mar;29(3):350-9.

PMID:
9125673
23.

Endothelin-1 mediated inhibition of the acetylcholine-activated potassium current from rabbit isolated atrial cardiomyocytes.

Spiers JP, Kelso EJ, McDermott BJ, Scholfield CN, Silke B.

Br J Pharmacol. 1996 Dec;119(7):1427-37.

24.

Mechanical effects of ET-1 in cardiomyocytes isolated from normal and heart-failed rabbits.

Kelso EJ, Geraghty RF, McDermott BJ, Trimble ER, Nicholls DP, Silke B.

Mol Cell Biochem. 1996 Apr 12-26;157(1-2):149-55.

PMID:
8739241
25.

Actions of the novel vasodilator, flosequinan, in isolated ventricular cardiomyocytes.

Kelso EJ, McDermott BJ, Silke B.

J Cardiovasc Pharmacol. 1995 Mar;25(3):376-86.

PMID:
7769801
26.
27.

Supplemental Content

Loading ...
Support Center